HK1072935A1 - Condensed camptothecins as antitumor agents - Google Patents
Condensed camptothecins as antitumor agentsInfo
- Publication number
- HK1072935A1 HK1072935A1 HK05104506A HK05104506A HK1072935A1 HK 1072935 A1 HK1072935 A1 HK 1072935A1 HK 05104506 A HK05104506 A HK 05104506A HK 05104506 A HK05104506 A HK 05104506A HK 1072935 A1 HK1072935 A1 HK 1072935A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- camptothecins
- condensed
- sup
- antitumor agents
- identified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01128361 | 2001-11-30 | ||
| PCT/EP2002/013216 WO2003045952A2 (en) | 2001-11-30 | 2002-11-25 | Condensed camptothecins as antitumor agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1072935A1 true HK1072935A1 (en) | 2005-09-16 |
Family
ID=8179394
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK05104506A HK1072935A1 (en) | 2001-11-30 | 2005-05-30 | Condensed camptothecins as antitumor agents |
| HK05109380A HK1077303A1 (en) | 2001-11-30 | 2005-10-21 | Hexacyclic compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK05109380A HK1077303A1 (en) | 2001-11-30 | 2005-10-21 | Hexacyclic compounds |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US6825194B2 (zh) |
| EP (1) | EP1480984B9 (zh) |
| JP (1) | JP4305909B2 (zh) |
| KR (1) | KR100895746B1 (zh) |
| CN (1) | CN100338066C (zh) |
| AT (1) | ATE398131T1 (zh) |
| AU (1) | AU2002356720B2 (zh) |
| BR (1) | BR0214615A (zh) |
| CA (1) | CA2468824C (zh) |
| DE (1) | DE60227113D1 (zh) |
| ES (1) | ES2307830T3 (zh) |
| GT (1) | GT200200250A (zh) |
| HK (2) | HK1072935A1 (zh) |
| HU (1) | HUP0500062A3 (zh) |
| IL (1) | IL162058A0 (zh) |
| MX (1) | MXPA04005185A (zh) |
| MY (1) | MY136138A (zh) |
| NO (1) | NO329005B1 (zh) |
| NZ (1) | NZ533568A (zh) |
| PA (1) | PA8558901A1 (zh) |
| PE (1) | PE20030725A1 (zh) |
| PL (1) | PL207510B1 (zh) |
| RS (1) | RS51051B (zh) |
| RU (1) | RU2299212C2 (zh) |
| TW (1) | TWI258481B (zh) |
| UA (1) | UA80409C2 (zh) |
| UY (1) | UY27560A1 (zh) |
| WO (1) | WO2003045952A2 (zh) |
| ZA (1) | ZA200404522B (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1599484A2 (en) | 2003-02-21 | 2005-11-30 | Chugai Seiyaku Kabushiki Kaisha | Process for the preparation of hexacyclic camptothecin derivatives |
| JP4823894B2 (ja) | 2004-04-09 | 2011-11-24 | 中外製薬株式会社 | 新規水溶性プロドラッグ |
| TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
| CN101340913A (zh) * | 2005-10-19 | 2009-01-07 | 中外制药株式会社 | 包含新颖的水溶性前药的胰腺癌、卵巢癌或肝癌的预防或治疗剂 |
| BR112021018986A2 (pt) | 2019-03-29 | 2022-01-18 | Medimmune Ltd | Compostos e conjugados dos mesmos |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4473692A (en) | 1981-09-04 | 1984-09-25 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives and process for preparing same |
| US4939255A (en) * | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
| HU213136B (en) * | 1990-08-14 | 1997-02-28 | Kyorin Seiyaku Kk | Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them |
| JP3008226B2 (ja) * | 1991-01-16 | 2000-02-14 | 第一製薬株式会社 | 六環性化合物 |
| JP3359955B2 (ja) * | 1992-07-16 | 2002-12-24 | 第一製薬株式会社 | 抗腫瘍剤 |
| GB9402934D0 (en) * | 1994-02-16 | 1994-04-06 | Erba Carlo Spa | Camptothecin derivatives and process for their preparation |
| US5663177A (en) * | 1995-05-31 | 1997-09-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
| AU6272598A (en) | 1997-02-14 | 1998-09-08 | Bionumerik Pharmaceuticals, Inc. | Highly lipophilic camptothecin derivatives |
| GB9715821D0 (en) * | 1997-07-25 | 1997-10-01 | Pharmacia & Upjohn Spa | Amidino-camptothecin derivatives |
-
2002
- 2002-11-25 IL IL16205802A patent/IL162058A0/xx not_active IP Right Cessation
- 2002-11-25 KR KR1020047008223A patent/KR100895746B1/ko not_active IP Right Cessation
- 2002-11-25 BR BR0214615-0A patent/BR0214615A/pt not_active IP Right Cessation
- 2002-11-25 AU AU2002356720A patent/AU2002356720B2/en not_active Ceased
- 2002-11-25 UA UA20040605013A patent/UA80409C2/uk unknown
- 2002-11-25 WO PCT/EP2002/013216 patent/WO2003045952A2/en active IP Right Grant
- 2002-11-25 EP EP02803790A patent/EP1480984B9/en not_active Expired - Lifetime
- 2002-11-25 NZ NZ533568A patent/NZ533568A/en not_active IP Right Cessation
- 2002-11-25 RU RU2004119841/04A patent/RU2299212C2/ru not_active IP Right Cessation
- 2002-11-25 PL PL370479A patent/PL207510B1/pl not_active IP Right Cessation
- 2002-11-25 HU HU0500062A patent/HUP0500062A3/hu unknown
- 2002-11-25 RS YUP-470/04A patent/RS51051B/sr unknown
- 2002-11-25 DE DE60227113T patent/DE60227113D1/de not_active Expired - Lifetime
- 2002-11-25 ES ES02803790T patent/ES2307830T3/es not_active Expired - Lifetime
- 2002-11-25 CN CNB028277465A patent/CN100338066C/zh not_active Expired - Fee Related
- 2002-11-25 AT AT02803790T patent/ATE398131T1/de not_active IP Right Cessation
- 2002-11-25 CA CA2468824A patent/CA2468824C/en not_active Expired - Fee Related
- 2002-11-25 JP JP2003547402A patent/JP4305909B2/ja not_active Expired - Fee Related
- 2002-11-25 MX MXPA04005185A patent/MXPA04005185A/es active IP Right Grant
- 2002-11-26 US US10/304,672 patent/US6825194B2/en not_active Expired - Fee Related
- 2002-11-27 TW TW091134463A patent/TWI258481B/zh not_active IP Right Cessation
- 2002-11-28 MY MYPI20024479A patent/MY136138A/en unknown
- 2002-11-28 PA PA20028558901A patent/PA8558901A1/es unknown
- 2002-11-28 PE PE2002001148A patent/PE20030725A1/es not_active Application Discontinuation
- 2002-11-29 GT GT200200250A patent/GT200200250A/es unknown
- 2002-11-29 UY UY27560A patent/UY27560A1/es not_active Application Discontinuation
-
2004
- 2004-06-08 ZA ZA200404522A patent/ZA200404522B/en unknown
- 2004-06-29 NO NO20042729A patent/NO329005B1/no not_active IP Right Cessation
- 2004-09-16 US US10/942,044 patent/US7109195B2/en not_active Expired - Fee Related
-
2005
- 2005-05-30 HK HK05104506A patent/HK1072935A1/xx not_active IP Right Cessation
- 2005-10-21 HK HK05109380A patent/HK1077303A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1646389E (pt) | Derivados de pirimidina-2,4-diona utilizados como antagonistas do receptor da hormona libertadora de gonadotropina | |
| JO2311B1 (en) | Alkyl inhibitors Ariel phosphodiesterase-4 | |
| AP1655A (en) | A method of preparing quinazoline derivatives useful as anti-cancer compounds. | |
| IL172834A0 (en) | Pyrimidine-,2,4-dione derivatives and pharmaceutical compositions containing the same | |
| HK1068136A1 (en) | Muscarinic antagonists | |
| BG103417A (en) | Condensed pyrimidine bicyclic derivatives | |
| HRP20031003A2 (en) | 4'-substituted nukleosides | |
| MY138478A (en) | Benzazepine derivatives for the treatment of neurological disorders | |
| YU64303A (sh) | N-supstituisani nearil-heterociklični antagonisti nmda/nr2b | |
| BG106003A (en) | New n-cyanomethylamides and compositions as protease inhibitors | |
| MXPA06001494A (es) | Compuestos de piramidina condensados como inhibidores de canales ionicos gatillados por tension. | |
| GEP20074099B (en) | 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF | |
| PL373414A1 (en) | 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands | |
| WO2003022219A3 (en) | Biarylamino purine antiproliferative agents | |
| MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
| IL137964A0 (en) | Antitumor agents | |
| MY128241A (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
| AP2001002191A0 (en) | 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives. | |
| HK1072935A1 (en) | Condensed camptothecins as antitumor agents | |
| GEP20105095B (en) | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents | |
| AP2001002306A0 (en) | Bridged piperazine derivatives. | |
| IL158806A0 (en) | Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists | |
| MXPA04005151A (es) | Compuestos terapeuticos. | |
| MY129094A (en) | Condensed polycyclic compounds | |
| YU46302A (sh) | Supstituisani piroli |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CHRG | Changes in the register |
Free format text: CORRECTION OF THE CHINESE AND ENGLISH TITLE OF INVENTION FROM CONDENSED CAMPTOTHECINS AS ANTITUMOR AGENTS AND TO HEXACYCLIC COMPOUNDS AND |
|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20121125 |